Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
PCVX
#848
Vaxcyte, Inc. Common Stock
61.740
0
+3.31%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+3.31%
Monatliche Änderung
+13.62%
6 month change
+45.96%
Jahresänderung
+45.96%
Vorheriger Schlusskurs
59.760
0
Open
61.740
0
Bid
Ask
Low
61.740
0
High
61.740
0
Volumen
145
Märkte
Aktien
Gesundheitswesen
PCVX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
51.33 M
56.31 M
80.03 M
108.41 M
128.76 M
143.92 M
—
Valuation ratios
Enterprise value
977.58 M
1.27 B
2.94 B
6.43 B
10.15 B
6.47 B
19.34 B
Price to earnings ratio
—
—
-13.72
-15.2
-21.54
-8.2
-33.01
Price to sales ratio
—
—
2 022.62
3 223.57
2 282.67
—
—
Price to cash flow ratio
—
—
17.95
20.6
22.06
9.58
37.94
Price to book ratio
—
—
3.21
4.93
3.02
2.34
3.44
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.23
0.31
0.22
0.29
0.13
0.26
0.24
Return on equity %
0.26
0.35
0.23
0.32
0.14
0.29
0.26
Return on invested capital %
2 091.55
843.77
—
810.68
210.08
226.32
227.97
Gross margin %
100
100
100
100
100
—
—
Operating margin %
3 810.34
6 211.5
15.34 K
24.67 K
13.02 K
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
3 794.85
5 996.23
14.76 K
21.21 K
10.6 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.3
8.93
23.26
7.54
12.75
7.91
45.55
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0
0
0
0
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2.63
3.05
3.71
4.82
4.82
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
14.36
11.12
14.32
11.47
48.57
Net current asset value per share
—
—
14.53
11.28
14.66
11.96
50.2
Tangible book value per share
—
—
14.7
12.77
27.1
19.73
87.13
Working capital per share
—
—
13.9
9.78
13.51
10.45
45.37
Book value per share
—
—
14.7
12.77
27.1
19.73
87.13
Nachrichten
BTIG hebt Vaxcyte-Kursziel auf 89 US-Dollar wegen Wettbewerbsvorteil bei Impfstoff
BTIG raises Vaxcyte price target to $89 on vaccine breadth edge
Vaxcyte: Leerink hebt Kursziel nach Erweiterung der Impfstoff-Pipeline an
Leerink raises Vaxcyte stock price target on vaccine pipeline expansion
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Ovintiv to Report Q4 Earnings: What's in Store for the Stock?
Vaxcyte schließt Kapitalerhöhung über 632,5 Millionen US-Dollar ab
Vaxcyte closes $632.5 million public offering of common stock
Vaxcyte platziert Aktienemission im Wert von 550 Millionen US-Dollar
Vaxcyte prices $550 million public offering of common stock
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Vaxcyte launches $500 million public offering of common stock